Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1983 1
2001 1
2004 1
2005 1
2006 1
2007 1
2008 5
2009 1
2010 4
2011 4
2012 6
2013 5
2014 11
2015 10
2016 8
2017 9
2018 3
2019 2
2020 13
2021 12
2022 8
2023 3
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

100 results

Results by year

Filters applied: . Clear all
Page 1
The French Compassionate Program of elexacaftor-tezacaftor-ivacaftor in people with cystic fibrosis with advanced lung disease and no F508del CFTR variant.
Burgel PR, Sermet-Gaudelus I, Durieu I, Kanaan R, Macey J, Grenet D, Porzio M, Coolen-Allou N, Chiron R, Marguet C, Douvry B, Dufeu N, Danner-Boucher I, Foucaud P, Lemonnier L, Girodon E, Da Silva J, Martin C; French CF Reference Network study group. Burgel PR, et al. Among authors: chiron r. Eur Respir J. 2023 Feb 16:2202437. doi: 10.1183/13993003.02437-2022. Online ahead of print. Eur Respir J. 2023. PMID: 36796836
Multisystemic Effects of Elexacaftor-Tezacaftor-Ivacaftor in Adults with Cystic Fibrosis and Advanced Lung Disease.
Burgel PR, Paillasseur JL, Durieu I, Reynaud-Gaubert M, Hamidfar R, Murris-Espin M, Danner-Boucher I, Chiron R, Leroy S, Douvry B, Grenet D, Mely L, Ramel S, Montcouquiol S, Burnet E, Ouaalaya EH, Sogni P, Da Silva J, Martin C; Participating Investigators of the French Cystic Fibrosis Reference Network Study Group. Burgel PR, et al. Among authors: chiron r. Ann Am Thorac Soc. 2024 Jul;21(7):1053-1064. doi: 10.1513/AnnalsATS.202312-1065OC. Ann Am Thorac Soc. 2024. PMID: 38579175
Gathering real-world compassionate data to expand eligibility for elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis with N1303K or other rare CFTR variants: a viewpoint.
Burgel PR, Sermet-Gaudelus I, Girodon E, Kanaan R, Le Bihan J, Remus N, Ravoninjatovo B, Grenet D, Porzio M, Houdouin V, Le Clainche-Viala L, Durieu I, Nove-Josserand R, Languepin J, Coltey B, Guillaumot A, Audousset C, Chiron R, Weiss L, Fajac I, Da Silva J, Martin C; French CF Reference Network study group. Burgel PR, et al. Among authors: chiron r. Eur Respir J. 2024 Jan 25;63(1):2301959. doi: 10.1183/13993003.01959-2023. Print 2024 Jan. Eur Respir J. 2024. PMID: 38242629 No abstract available.
A model for active and healthy ageing with a rare genetic disease: cystic fibrosis.
Chiron R, Caimmi D, Valiulis A, Durieu I, Tejedor P, Le Cam Y, Boudes M, Jonquet O, Strandberg T, Michel JP, de Manuel Keenoy E, Demoly P, Mercier J, Bourret R, Bousquet J; MACVIA-LR European Innovation Partnership on Active and Healthy Ageing Reference Site. Chiron R, et al. Eur Respir J. 2016 Mar;47(3):714-9. doi: 10.1183/13993003.01237-2015. Eur Respir J. 2016. PMID: 26929314 Free article. Review. No abstract available.
Biologics in asthma: difficulties and drawbacks.
Bousquet J, Chiron R, Humbert M. Bousquet J, et al. Among authors: chiron r. Expert Opin Biol Ther. 2008 Dec;8(12):1921-8. doi: 10.1517/14712590802496928. Expert Opin Biol Ther. 2008. PMID: 18990078 Review.
[National consensus regarding azithromycin use in cystic fibrosis].
Abely M, Jubin V, Bessaci-Kabouya K, Chiron R, Bui S, Fayon M. Abely M, et al. Among authors: chiron r. Rev Mal Respir. 2015 Jun;32(6):557-65. doi: 10.1016/j.rmr.2014.10.733. Epub 2015 May 21. Rev Mal Respir. 2015. PMID: 26003196 Review. French.
COBRAPed cohort: Do sensitization patterns differentiate children with severe asthma from those with a milder disease?
Lejeune S, Bouazza N, Nicaise PR, Jolaine V, Roditis L, Marguet C, Amat F, Berger P, Fayon M, Dubus JC, Valois S, Reix P, Pellan M, Brouard J, Chiron R, Giovannini-Chami L, de Blic J, Deschildre A, Lezmi G; COBRAPed Study Group. Lejeune S, et al. Among authors: chiron r. Pediatr Allergy Immunol. 2024 Mar;35(3):e14112. doi: 10.1111/pai.14112. Pediatr Allergy Immunol. 2024. PMID: 38520021
[Measurement of pulmonary inflammation in cystic fibrosis].
Fayon M, Chiron R, Abely M; pour le Groupe "Inflammation" de la Société Française de la Mucoviscidose. Fayon M, et al. Among authors: chiron r. Rev Mal Respir. 2008 Jun;25(6):705-24. doi: 10.1016/s0761-8425(08)73800-2. Rev Mal Respir. 2008. PMID: 18772828 Review. French.
100 results